Year: 2011
Type: article
Abstract: treatment, and allows the establishment of a stable donor chimerism.Of note, ABO incompatibility is not a major obstacle to transplantation and modern management can prevent infertility, even in females as recently demonstrated in the litterature.4 In conclusion, we think that innovative nonmyeloablative protocols are crucial for the future of HSCT for older SCD patients with organ failure, but there is still a place for myeloablative regimens for young SCD adults who experience more severe disease with aging.
Source: Blood
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: National Institutes of Health
OpenAlex ID: W1995990398
